Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer

Description

This pilot trial studies a telephone-based intervention to see if it increases adherence to adjuvant hormonal therapy in patients with breast cancer. Increasing communication between doctors and patients with breast cancer may help patients to better follow recommendations on taking adjuvant hormonal treatment medication. A telephone-based intervention may help to increase doctor-patient communication and patients' adherence to their prescribed medication.

Conditions

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage 0 Breast Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This pilot trial studies a telephone-based intervention to see if it increases adherence to adjuvant hormonal therapy in patients with breast cancer. Increasing communication between doctors and patients with breast cancer may help patients to better follow recommendations on taking adjuvant hormonal treatment medication. A telephone-based intervention may help to increase doctor-patient communication and patients' adherence to their prescribed medication.

Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility

Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer

Condition
Stage IA Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Goldsboro

Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States, 27534

Winston-Salem

Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States, 27157

Columbus

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States, 43210

Burlington

Fletcher Allen Health Care-Medical Center, Burlington, Vermont, United States, 05401

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Eligible women are those who:
  • * Are post-menopausal, verified by:
  • * Post bilateral surgical oophorectomy; or
  • * No spontaneous menses \>= 1 year; or
  • * No menses for \< 1 year with follicle stimulating hormone (FSH) and estradiol levels in postmenopausal range, according to institutional standards
  • * Are diagnosed with primary breast cancer (BC) (stages I-III)
  • * Eligible to receive AHT (tamoxifen or an aromatase inhibitors \[AI\]) for the first time
  • * Completed all primary treatment
  • * Own a smartphone (in order to receive text messages and utilize the phone app)
  • * Agree to receive text messages on their smartphone over a 3-month period
  • * Provide consent and permission to review their medical records
  • * Plan to stay in the study area for 3 months

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Ohio State University Comprehensive Cancer Center,

Michelle Naughton, PhD, MPH, PRINCIPAL_INVESTIGATOR, Ohio State University Comprehensive Cancer Center

Study Record Dates

2025-08-31